These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3186723)

  • 1. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.
    Seto E; Yen TS; Peterlin BM; Ou JH
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8286-90. PubMed ID: 3186723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 rev protein as a negative trans-regulator.
    Sadaie MR; Benaissa ZN; Cullen BR; Wong-Staal F
    DNA; 1989 Nov; 8(9):669-74. PubMed ID: 2693023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.
    Twu JS; Rosen CA; Haseltine WA; Robinson WS
    J Virol; 1989 Jun; 63(6):2857-60. PubMed ID: 2724417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis.
    Twu JS; Wu JY; Robinson WS
    Virology; 1990 Jul; 177(1):406-10. PubMed ID: 2191500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ; Elder J; Neil JC
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
    Tao J; Frankel AD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X protein produced in Escherichia coli is biologically functional.
    Jameel S; Siddiqui A; Maguire HF; Rao KV
    J Virol; 1990 Aug; 64(8):3963-6. PubMed ID: 2196386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.
    Levrero M; Balsano C; Natoli G; Avantaggiati ML; Elfassi E
    J Virol; 1990 Jun; 64(6):3082-6. PubMed ID: 2335828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
    Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.
    Kumar V; Jayasuryan N; Kumar R
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5647-52. PubMed ID: 8643631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.
    Balsano C; Billet O; Bennoun M; Cavard C; Zider A; Grimber G; Natoli G; Briand P; Levrero M
    Arch Virol Suppl; 1993; 8():63-71. PubMed ID: 8260878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
    Kashanchi F; Wood C
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ; Loewenstein PM; Green M
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product.
    Sol N; Morinet F; Alizon M; Hazan U
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():2011-4. PubMed ID: 8376975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.